Vireo Growth Secures $85M Revolving Credit Facility, Completes $48.7M PharmaCann Acquisition
VREOF sits 25% above its 52-week low of $8.91 on elevated volume (3.9× avg).
Summary
Vireo Growth Inc. secured a new $85M (expandable to $105M) revolving credit facility to fund its operations and acquisitions, and completed the $48.7M PharmaCann Colorado retail asset acquisition, expanding its dispensary footprint.
Key Events · Financing and Capital Events · VREOF
-
New Revolving Credit Facility Secured
Vireo Growth Inc. entered into a senior secured asset-based revolving credit facility with initial commitments of $85 million, expandable to $105 million. The five-year facility, led by Bank of Montreal, will refinance existing debt, fund working capital, capital expenditures, and future acquisitions.
-
PharmaCann Acquisition Completed
The company completed the previously announced acquisition of 17 Colorado retail cannabis dispensaries from PharmaCann Inc. for approximately $48.7 million. The consideration included the issuance of 3,004,751 subordinate voting shares and assumed liabilities, expanding Vireo's Colorado footprint to 56 locations.
-
Strategic Integration
The completion of the PharmaCann acquisition marks the conclusion of the Management Services Agreement, with the acquired operations now fully integrated into Vireo's existing Colorado platform, aligning with the company's operational excellence and growth initiatives.
Analysis · VREOF · Life Sciences
Vireo Growth Inc. has secured a new senior secured asset-based revolving credit facility of up to $85 million, with an accordion feature allowing for an additional $20 million, bringing the potential total to $105 million. This five-year facility, led by Bank of Montreal, will be used to refinance existing indebtedness, fund working capital, capital expenditures, general corporate purposes, and finance permitted acquisitions. This provides substantial financial flexibility to support the company's aggressive growth strategy. Concurrently, the company announced the completion of its previously disclosed acquisition of certain Colorado retail cannabis assets from PharmaCann Inc. for approximately $48.7 million, paid through the issuance of 3,004,751 subordinate voting shares and assumed liabilities. This acquisition adds 17 dispensaries, expanding Vireo's Colorado retail footprint to 56 operational locations, and marks the full integration of these operations following a management services agreement.
At the time of this filing, VREOF was trading at $11.10 on OTC in the Life Sciences sector, with a market capitalization of approximately $547.3M. The 52-week trading range was $8.91 to $24.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.